Hsbc Holdings PLC Takes $333,000 Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Hsbc Holdings PLC purchased a new stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 11,841 shares of the company’s stock, valued at approximately $333,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. FIL Ltd acquired a new position in Maravai LifeSciences during the 4th quarter worth approximately $18,467,000. Alyeska Investment Group L.P. acquired a new position in Maravai LifeSciences during the 4th quarter worth approximately $29,744,000. Jefferies Group LLC acquired a new position in Maravai LifeSciences during the 4th quarter worth approximately $2,259,000. Jennison Associates LLC acquired a new position in Maravai LifeSciences during the 4th quarter worth approximately $7,444,000. Finally, Victory Capital Management Inc. acquired a new position in Maravai LifeSciences during the 4th quarter worth approximately $2,946,000.

MRVI has been the topic of several recent analyst reports. Jefferies Financial Group initiated coverage on Maravai LifeSciences in a research report on Tuesday, December 15th. They set a “buy” rating on the stock. KeyCorp upped their price target on Maravai LifeSciences from $39.00 to $46.00 and gave the stock an “overweight” rating in a report on Tuesday, March 9th. Morgan Stanley upped their price target on Maravai LifeSciences from $35.00 to $54.00 and gave the stock an “overweight” rating in a report on Tuesday, March 9th. Robert W. Baird assumed coverage on Maravai LifeSciences in a report on Tuesday, December 15th. They issued an “outperform” rating and a $31.00 price target on the stock. Finally, Zacks Investment Research cut Maravai LifeSciences from a “buy” rating to a “hold” rating in a report on Thursday, April 8th. One investment analyst has rated the stock with a hold rating and ten have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $38.33.

MRVI stock opened at $37.51 on Wednesday. Maravai LifeSciences Holdings, Inc. has a 1 year low of $23.62 and a 1 year high of $40.24. The company has a 50 day moving average of $34.73.

Maravai LifeSciences (NASDAQ:MRVI) last posted its earnings results on Monday, March 1st. The company reported $0.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.02. The company had revenue of $98.35 million during the quarter, compared to analysts’ expectations of $87.48 million. As a group, equities analysts forecast that Maravai LifeSciences Holdings, Inc. will post 0.36 earnings per share for the current year.

About Maravai LifeSciences

There is no company description available for Maravai LifeSciences Holdings Inc

Further Reading: Stochastic Momentum Index (SMI)

Want to see what other hedge funds are holding MRVI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI).

Institutional Ownership by Quarter for Maravai LifeSciences (NASDAQ:MRVI)

Receive News & Ratings for Maravai LifeSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maravai LifeSciences and related companies with MarketBeat.com's FREE daily email newsletter.